CNTX Company Profile and Key Details
Context Therapeutics Inc.
CNTX Stock Price Chart
Stock Price Today
Context Therapeutics Inc. (CNTX) stock declined over -4.74%, trading at $0.87 on NASDAQ, down from the previous close of $0.91. The stock opened at $0.91, fluctuating between $0.87 and $0.94 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
Philadelphia, PA 19103
United States
Website: https://www.contexttherapeutics.comContact: 267 225 7416About Company
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also developing CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for gynaecologic cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Company Information
| Employees | 5 |
| Beta | 2.25 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Context Therapeutics Inc. (NASDAQ: CNTX) stock price is $0.87 in the last trading session. During the trading session, CNTX stock reached the peak price of $0.94 while $0.87 was the lowest point it dropped to. The percentage change in CNTX stock occurred in the recent session was -4.74% while the dollar amount for the price change in CNTX stock was -$0.04.
The NASDAQ listed CNTX is part of Biotechnology industry that operates in the broader Healthcare sector. Context Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Christopher Beck M.B.A.
Senior Vice President of Operations
Dr. Felix Kim Ph.D.
Co-founder & Chair of Scientific Advisory Board
Dr. Tarek Sahmoud M.D., Ph.D.
Chief Medical Officer
Mr. Alex C. Levit Esq.
Chief Legal Officer & Corporation Sec.
Ms. Jennifer Minai-Azary
Chief Financial Officer & Treasurer
Dr. Evan G. Dick
Senior Vice President of R&D
Mr. Martin A. Lehr
Co-Founder, Pres, Chief Executive Officer & Director
Ms. Elizabeth Nemchik CPA
Controller
CNTX's closing price is 15.03% higher than its 52-week low of $0.79 where as its distance from 52-week high of $2.75 is -66.79%.
Number of CNTX employees currently stands at 5.
Official Website of CNTX is: https://www.contexttherapeutics.com
CNTX could be contacted at phone 267 225 7416 and can also be accessed through its website. CNTX operates from 2001 Market Street, Philadelphia, PA 19103, United States.
CNTX stock volume for the day was 37.15K shares. The average number of CNTX shares traded daily for last 3 months was 510.81K.
The market value of CNTX currently stands at $65.25M with its latest stock price at $0.87 and 75M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com